FDA Approves Unknown Drug — HIKMA

# FDA Approves Hikma Generic Drug Application Hikma Pharmaceuticals has received FDA approval for an abbreviated new drug application (ANDA 074060), positioning the company to expand its generic drug portfolio and capture additional market share in the competitive pharmaceuticals sector. The approval, granted on January 13, 1995, marks a milestone for the company's generic drug manufacturing capabilities and is expected to strengthen its competitive position in the U.S. market.